Menstrual regulation as a treatment of secondary amenorrhea in contraceptive users.

The safety and efficacy of menstrual regulation (MR) for the treatment of secondary amenorrhea in women who are no more than 14 days past an expected menstrual period was evaluated in 279 cases. The incidence of serious complications such as prolonged bleeding and pelvic infection was 5.7%. The incidence of vasovagal reaction was significantly (p less than .1) higher among patients who had an IUD inserted immediately after MR (11.2%) compared with patients who did not (6.6%). The procedure failed to terminate pregnancy in 2.3% of the patients. The Pregnosticon Dri-Dot test did not appear to be effective in distinguishing those patients who were pregnant and those who were not.